Filing Flows › Industrials › OneMedNet (ONMD)
OneMedNet (ONMD) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · OneMedNet (ONMD) Q2 2026 earnings results →
Q2 2026 Revenue up 88% year over year to $292K · 744¢ of every $1 of revenue lost · operating margin -774.3%
OneMedNet made $292K in Q2 2026 (+88% Y/Y). Operating margin -774.3%, net loss $2.2M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $292K in Q2 2026, up 88% year over year and up 204% from the previous quarter.
Operating costs exceeded revenue by $2.3M, an operating margin of -774.3%. Total costs grew 15% against revenue growth of 88%. The fastest-growing cost line was Cost of revenue (+116%). The quarter ended with a net loss of $2.2M, narrower than the previous quarter's $2.5M loss.
Operating cash flow was −$1.9M. Non-cash charges added back $463K of share-based compensation. Working capital and other items used $166K. Capital expenditures of $9K exceeded it, leaving free cash flow of −$1.9M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 14, 2026 | $292K | +88% | -774.3% | −$2.2M | −$1.9M |
| Q1 2026 | 10-Q | May 15, 2026 | $96K | -30% | n/m | −$2.5M | −$1.5M |
| Q4 2025 | 10-K | Mar 30, 2026 | $891K | 34× | -345.9% | −$3.1M | −$1.7M |
| Q3 2025 | 10-Q | Nov 14, 2025 | $177K | +25% | n/m | −$741K | −$1.7M |
| Q2 2025 | 10-Q | Aug 13, 2025 | $155K | -32% | n/m | $3.0M | −$2.2M |
| Q1 2025 | 10-Q | May 14, 2025 | $137K | -45% | n/m | −$1.9M | −$1.9M |
| Q4 2024 | 10-K | Apr 15, 2025 | $26K | -92% | n/m | −$2.4M | −$2.0M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About OneMedNet
OneMedNet is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWDTM”). OneMedNet’s innovative solutions connect healthcare providers and patients satisfying a crucial need within the life sciences field offering direct access to clinical images and the associated contextual patient record. OneMedNet’s innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet’s life science partners case selection protocols and paves the way for Real World Evidence (as defined below).
In its own words, from its 10-K, filed Mar 30, 2026.
OneMedNet against its Services-Commercial Physical & Biological Research peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +88% against the peers' median +8%. Operating margin: -774.3% against the peers' median 12.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ONMD OneMedNet | Q2 2026 | $292K | +88% | -774.3% |
| IQV IQVIA Holdings | Q3 2026 | $4.4B | +8% | 12.9% |
| INCY Incyte | Q3 2026 | $1.6B | +14% | -45.5% |
| CRL Charles River Laboratories International | Q3 2026 | $983M | -2% | 20.6% |
| MEDP Medpace Holdings | Q3 2026 | $716M | +8% | 23.1% |
| NRC NRC Health | Q3 2026 | $38.4M | +11% | 23.2% |
| MXCT Maxcyte | Q2 2026 | $7.3M | -14% | -140.7% |
| FOXO Foxo Technologies | Q2 2026 | $4.7M | -10% | 185.5% |
| OABI OmniAb | Q3 2026 | $4.0M | +78% | -409.9% |
Source: OneMedNet 10-Q on SEC EDGAR · CIK 1849380 · Services-Commercial Physical & Biological Research
More on ONMD
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results